Investor Presentaiton slide image

Investor Presentaiton

Novo Nordisk Annual Report 2023 Financial statements of the parent company 4 Financial income and financial expenses DKK million 6 Intangible assets 2023 2022 DKK million Interest income relating to subsidiaries 487 365 Cost at the beginning of the year Intellectual property rights 20,167 Software and other intangibles 2023 2022 3,653 23,820 12,572 Interest income relating to external counterparties 936 170 Foreign exchange gain (net) 772 Financial gain from forward contracts (net) 1,263 Additions during the year Disposals during the year Cost at the end of the year 11,347 490 11,837 11,399 (151) 31,514 4,143 35,657 23,820 Capital gain from marketable securities 144 Amortisation at the beginning of the year 2,672 1,699 4,371 3,462 Other financial income 34 32 Amortisation during the year 840 171 1,011 810 Total financial income 3,636 567 Impairment losses for the year 1,499 21 1,520 250 Interest expenses relating to subsidiaries 4,225 1,150 Amortisation and impairment losses reversed on disposals during the year (151) Result of associated company 38 4 Amortisation at the end of the year 5,011 1,891 6,902 4,371 Foreign exchange loss (net) 2,705 Carrying amount at the end of the year 26,503 2,252 28,755 19,449 Financial loss from forward contracts (net) 1,659 Capital loss from marketable securities Other financial expenses Total financial expenses 5 Deferred income tax assets/(liabilities) 463 Intangible assets primarily relate to intellectual property rights, internally developed software and costs related to major IT projects. Intangible assets which are not yet available for use amount to DKK 19,993 million (DKK 10,007 million in 2022). 318 299 4,581 6,280 DKK million 2023 2022 Net deferred tax asset/(liability) at the beginning of the year (2,967) 228 Income/(charge) to the income statement (2,797) (2,629) Income/(charge) to equity (518) (566) Net deferred tax asset/(liability) at the end of the year (6,282) (2,967) The Danish corporate tax rate is 22% in 2023 (22% in 2022). 108
View entire presentation